Global Nephrostomy Bags Market By Type (Sterile and Non-sterile), By Usage (Disposable and Reusable), By Capacity (100-500 ml, 500-1000 ml, and Above 1000 ml), By Material (PVC and PU, Silicone, Others), By End-User (Hospitals & Clinics, Homecare, Ambulatory Surgical Centers, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview

Nephrostomy Bags Market size is expected to be worth around US$ 1.5 Billion by 2033 from US$ 1.0 Billion in 2024, growing at a CAGR of 4.2% during the forecast period from 2024 to 2033.

The nephrostomy bags market is influenced by several critical factors, including the increasing prevalence of chronic kidney diseases (CKD) and kidney failure, which are primary drivers of demand for renal drainage solutions. Additionally, the aging population, coupled with a growing incidence of diabetes and hypertension, further accelerates the adoption of nephrostomy bags in the market. Technological advancements in product design, such as improved comfort, odour control, and anti-reflux features, enhance patient compliance and broaden market appeal.

• For example, the CDC’s National Healthcare Safety Network (NHSN) reports that urinary tract infections account for about 32% of all healthcare-associated infections in U.S. hospitals, many of which are related to catheter use, including nephrostomy tubes.

Additionally, the shift towards home healthcare, where patients manage their conditions outside of clinical settings, boosts demand for more discreet and user-friendly products. However, challenges such as high costs, regulatory hurdles, and potential complications like infections limit growth. Competitive pressures, including pricing and innovation, push companies to develop cost-effective, eco-friendly, and sustainable solutions.

Key Takeaways

• The nephrostomy bags market was valued at USD 1.0 billion in 2024 and is anticipated to register substantial growth of USD 1.5 billion by 2034, with 4.2% CAGR.
• In 2024, the sterile segment took the lead in the global market, securing 85.02% of the total revenue share.
• The disposable segment took the lead in the global market, securing 78.12% of the total revenue share.
• The 500-1000 ml segment took the lead in the global market, securing 55.55% of the total revenue share.
• The PVC and PU segment took the lead in the global market, securing 45.15% of the total revenue share.
• The hospitals & clinics segment took the lead in the global market, securing 56.22% of the total revenue share.

Type Analysis

Based on type the market is fragmented into sterile and non-sterile. Amongst these, sterile segment dominated the nephrostomy bags market capturing a significant market share of 85.02% in 2024. The demand for sterile nephrostomy bags is amplified by the rising prevalence of kidney-related conditions, such as hydronephrosis, kidney stones, and urological cancers, particularly among the aging population.

This demographic requires safe, reliable products that align with their long-term care needs, further bolstering the market for sterile options. Additionally, advancements in bag designs, including anti-reflux valves, biocompatible materials, and enhanced durability, have improved patient comfort and outcomes, making these products more appealing for both hospital and homecare settings.

• According to NIH, in 2023, each year, around 600,000 adults in the U.S. are affected by kidney stones, impacting nearly 1 in 11 individuals. According to the National Health and Nutrition Examination Survey (NHANES), the prevalence of kidney stones in the U.S. is 8.8%. Among men, it stands at 10.6%, while for women, it is 7.1%.
• As per American Cancer Society, bladder cancer ranks as the 10th leading cause of cancer-related deaths in the United States. The likelihood of a woman dying from bladder cancer is approximately 1 in 333 (about 0.3%), while for men, the chance is about 1 in 125 (around 0.8%).

Usage Analysis

The market is fragmented by usage into disposable and reusable. Disposable dominated the nephrostomy bags market capturing a significant market share of 78.12% in 2024. These products are especially suited for short-term use and patients transitioning from hospital care to home settings, eliminating the need for maintenance and offering a convenient replacement solution.

Moreover, advancements in product design, including leak-proof features, anti-reflux valves, and secure connectors, enhance patient comfort and safety, boosting their appeal among healthcare providers and patients. From an economic perspective, disposable nephrostomy bags provide a cost-effective solution for healthcare facilities, particularly in scenarios where the operational costs of cleaning and sterilizing reusable bags may outweigh the expense of single-use options.

Overall, the strong emphasis on patient safety, coupled with the operational efficiency and technological enhancements of disposable nephrostomy bags, has solidified their position as the leading segment in the U.S. nephrostomy bags market. This trend reflects a growing preference for products that align with modern healthcare demands for convenience, hygiene, and cost management.

Capacity Analysis

The market is fragmented by capacity into 100-500 ml, 500-1000 ml, and above 1000 ml. 500-1000 ml dominated the nephrostomy bags market capturing a significant market share of 55.55% in 2024. Nephrostomy bags within the 500-1000 ml range strike a balance between usability and convenience, making them highly suitable for various clinical and home care settings.

These bags are particularly favored for their ability to accommodate moderate to high urine output, reducing the frequency of emptying and thereby enhancing patient comfort and caregiver efficiency. This feature is especially critical in hospital environments and long-term care facilities, where minimizing intervention and ensuring hygiene are priorities.

The widespread adoption of this segment can also be attributed to its versatility. Patients with varying activity levels, from those who are mobile to those who are bedridden, benefit from the medium-capacity bags. They are large enough to prevent overflows during prolonged use yet compact enough to support patient mobility when needed. This adaptability caters to a broad spectrum of patient needs, making it a popular choice among healthcare providers.

Material Analysis

The market is fragmented by material into PVC and PU, silicone, and others. PVC and PU dominated the nephrostomy bags market capturing a significant market share of 45.15% in 2024. The segment’s projected dominance can also be attributed to the growing demand for single-use, disposable medical products, where PVC and PU materials excel in ensuring safety and preventing infections.

As innovation continues to improve material properties, such as reducing environmental impact and enhancing recyclability, the PVC and PU segment is likely to sustain its leadership position, addressing both clinical needs and patient comfort effectively.

End-User Analysis

The market is fragmented by end-user into hospitals & clinics, homecare, ambulatory surgical centers, and others. Hospitals & clinics dominated the nephrostomy bags market capturing a significant market share of 56.22% in 2024. Hospitals and clinics provide 24/7 monitoring and support, which is particularly critical for patients with high-risk conditions. Their ability to offer tailored care plans, including the selection of appropriate nephrostomy bags based on patient needs, further underscores their leadership in this segment.

These facilities also frequently handle patients requiring long-term drainage solutions, boosting demand for high-quality nephrostomy bags. Another contributing factor to the segment’s dominance is the adoption of single-use, disposable nephrostomy bags in hospitals and clinics. These products minimize infection risks and enhance hygiene standards, aligning with stringent healthcare regulations.

Furthermore, the presence of skilled healthcare professionals ensures proper use and management of nephrostomy bags, fostering patient safety and recovery. As the prevalence of chronic kidney and urological disorders increases, the demand for nephrostomy procedures and related products in hospitals and clinics is expected to grow. The combination of high patient volumes, advanced care capabilities, and adherence to safety standards positions hospitals and clinics as the largest contributors to the nephrostomy bags market in the end-user segment.

Key Segments Analysis

Type

• Sterile
• Non-sterile

Usage

• Disposable
• Reusable

Capacity

• 100-500 ml
• 500-1000 ml
• Above 1000 ml

Material

• PVC and PU
• Silicone
• Others

End-User

• Hospitals & Clinics
• Homecare
• Ambulatory Surgical Centers
• Others

Market Dynamics

Increasing Surgical Procedures and Hospital Admissions

The increasing number of surgical procedures is significantly driving the growth of the nephrostomy bags market. As surgical techniques continue to advance, there has been a rise in complex surgeries across various specialties, including those related to abdominal, gastrointestinal, and urological procedures.

Nephrostomy bags are critical for post-operative care, especially when urine drainage is necessary due to obstructions or surgical interventions affecting the urinary tract. These bags ensure proper drainage and reduce the risk of complications, such as infections or fluid retention, which can impede recovery. With more patients undergoing surgeries that involve the urinary system or require prolonged post-operative care, the demand for nephrostomy bags has surged.

Additionally, as the healthcare system continues to focus on improving surgical outcomes and reducing hospital stay lengths, nephrostomy bags have become essential tools for managing patients during recovery. As surgical procedures increase in both volume and complexity, particularly in older populations and those with pre-existing conditions, the need for effective post-surgical care products like nephrostomy bags is expected to grow, ensuring continued market expansion.

• According to the Centers for Disease Control and Prevention (CDC), in 2020, there were approximately 48 million surgeries performed annually in the United States. This includes a wide range of procedures, from inpatient surgeries to outpatient and emergency surgeries. This figure reflects both major and minor surgeries performed across various medical fields, highlighting the extensive role of surgery in the U.S. healthcare system.

Restraints

Risk of Infections

The nephrostomy bags market is the risk of infections and complications associated with prolonged catheter use, which can impact patient outcomes and limit market growth. Nephrostomy procedures involve inserting a catheter through the skin into the kidney to drain urine, but long-term use increases the risk of infections, such as catheter-associated urinary tract infections (CAUTIs) and sepsis. Additionally, leakage, blockage, and dislodgement of nephrostomy tubes are common concerns, leading to frequent hospital visits and higher healthcare costs.

These complications may deter patients and healthcare providers from opting for nephrostomy procedures, particularly when alternative treatments, such as ureteral stents or minimally invasive laser procedures, are available. Regulatory bodies like the FDA impose strict quality and safety standards for medical devices, increasing compliance costs for manufacturers and potentially slowing down innovation.

Opportunities

Technological Innovations, such as Antimicrobial Coatings and Smart Monitoring Systems

Technological innovations are playing a significant role in creating growth opportunities for the nephrostomy bags market, with advancements such as antimicrobial coatings and smart monitoring systems making nephrostomy bags more effective, safer, and easier to use. These innovations address many of the key challenges faced by patients and healthcare providers, including the risk of infections, patient comfort, and ease of monitoring.

Antimicrobial coatings on nephrostomy bags are one of the most notable innovations, as they help reduce the risk of infections, a major concern with the use of urinary drainage systems. These coatings work by preventing bacterial growth on the surface of the bag and tubing, thus reducing the likelihood of urinary tract infections (UTIs) and kidney infections, which can result from prolonged use or improper care.

The reduction in infection rates can lead to better patient outcomes, fewer hospital readmissions, and reduced healthcare costs, ultimately encouraging more patients to adopt nephrostomy bags. As the healthcare industry increasingly prioritizes patient safety, antimicrobial-coated products are becoming an attractive solution, creating a competitive advantage for manufacturers who integrate this technology.

Impact of macroeconomic factors / Geopolitical factors

The global nephrostomy bags market is significantly influenced by macroeconomic and geopolitical factors, impacting supply chains, pricing, and market accessibility. Inflation, fluctuating healthcare expenditures, and reimbursement policies affect patient affordability and hospital procurement decisions. Economic downturns can limit government healthcare budgets, slowing the adoption of advanced nephrostomy solutions.

Geopolitical tensions, including trade restrictions, supply chain disruptions, and raw material shortages, have created uncertainties in the medical device industry. For instance, the U.S. China trade conflict and the Russia-Ukraine war have led to increased costs for essential medical components and logistics, causing potential delays in product availability.

Additionally, regulatory shifts and stricter quality compliance in different regions impact market entry and operational costs for manufacturers. Companies are adapting by diversifying supply chains, investing in localized production, and developing cost-effective alternatives to ensure steady market growth despite these challenges. Strategic planning and innovation remain crucial to mitigating macroeconomic and geopolitical risks.

Latest Trends

The global nephrostomy devices market is experiencing significant growth, driven by the increasing prevalence of kidney disorders and a rising preference for minimally invasive surgical procedures. Technological advancements have led to the development of more efficient and patient-friendly devices, such as improved nephrostomy catheters and drainage tubes. Leading companies are investing in innovative solutions to enhance procedural outcomes and patient comfort.

Additionally, there is a growing preference for outpatient settings, like ambulatory surgical centers, for these procedures, owing to their convenience and cost-effectiveness. Government initiatives aimed at raising awareness about kidney health and the importance of early intervention are further propelling market expansion. Overall, the nephrostomy devices market is poised for continued growth, supported by medical advancements and an increasing focus on minimally invasive treatment options.

Regional Analysis

North America dominated the nephrostomy bags market due to its well-established healthcare infrastructure, high prevalence of kidney-related disorders, and increasing adoption of advanced medical technologies. The region, particularly the U.S., experiences a rising number of cases of kidney stones, bladder cancer, and other urological conditions, driving the demand for nephrostomy procedures.

Favourable reimbursement policies and widespread health insurance coverage further support market growth by improving patient access to these medical devices. Additionally, leading manufacturers and key industry players, such as Becton Dickinson and Boston Scientific, have a strong presence in North America, contributing to product innovation and market expansion. The region also benefits from continuous R&D investments and regulatory support for medical device development, ensuring high-quality and efficient nephrostomy solutions.

Key Regions and Countries

North America

• US
• Canada

Europe

• Germany
• France
• The UK
• Spain
• Italy
• Russia
• Netherland
• Rest of Europe

Asia Pacific

• China
• Japan
• South Korea
• India
• New Zealand
• Singapore
• Thailand
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa

• South Africa
• Saudi Arabia
• UAE
• Rest of MEA

Key Players Analysis

The nephrostomy devices market is characterized by the presence of several key players driving innovation and competition. Prominent companies in this sector include Boston Scientific Corporation, Cook Medical, Coloplast Ltd., Becton, Dickinson and Company (BD), Teleflex Incorporated, and B. Braun Melsungen AG. These industry leaders offer a comprehensive range of nephrostomy products, such as catheters, guidewires, and drainage tubes, catering to diverse clinical needs.

Their strong market positions are attributed to extensive product portfolios, continuous research and development efforts, and strategic initiatives like mergers and acquisitions. For instance, Cook Medical has been recognized as a leading competitor in the nephrostomy devices market, offering products like the Cook®-Cope Loop and Ultrathane® nephrostomy sets.

Top Key Players

• Remington Medical
• Coloplast A/S
• Merit Medical
• UreSil, LLC
• Urocare Products, Inc.
• TERUMO Corporation
• Cardinal Health, Inc.
• Teleflex Incorporated
• B. Braun SE
• Becton, Dickinson and Company.

Recent Developments

• In September 2020, The Healthcare Plastics Recycling Council (HPRC) announced Remington Medical as its latest member. Remington Medical manufactures single-use, disposable medical products, such as drainage bags, syringes, needles, and cables.

Report Scope